L-arginine supplementation reduces mortality and improves disease outcome in mice infected with Trypanosoma cruzi.

• Main Authors: Sofía Carbajosa (Author), Héctor O Rodríguez-Angulo (Author), Susana Gea (Author), Carlos Chillón-Marinas (Author), Cristina Poveda (Author), María C Maza (Author), Diana Colombet (Author), Manuel Fresno (Author), Núria Gironès (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2018-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Chagas disease caused by Trypanosoma cruzi is a neglected disease that affects about 7 million people in Latin America, recently emerging on other continents due to migration. As infection in mice is characterized by depletion of plasma L-arginine, the effect on infection outcome was tested in mice...